Fluorescence Guided Minimally-Invasive Resection Of Abdominal Paragangliomas Using Indocyanine Green
Condition(s):ParagangliomaLast Updated:December 4, 2023Recruiting
Hide Studies Not Open or Pending
Condition(s):ParagangliomaLast Updated:December 4, 2023Recruiting
Condition(s):Fluorescence; Indocyanine Green; Rectal Cancer SurgeryLast Updated:September 13, 2023Recruiting
Condition(s):Meniscus RuptureLast Updated:June 16, 2022Not yet recruiting
Condition(s):Intraoperative Fluorescence AngiographyLast Updated:August 22, 2023Not yet recruiting
Condition(s):Esophageal Cancer; Gastric CancerLast Updated:January 8, 2024Recruiting
Condition(s):Ovarian CancerLast Updated:April 18, 2023Recruiting
Condition(s):Cancer ProstateLast Updated:January 15, 2019Terminated
Condition(s):Cholelithiasis; Gallbladder PolypsLast Updated:March 14, 2018Completed
Condition(s):Low Grade Glioma (LGG); High Grade Glioma (HGG)Last Updated:October 5, 2016Completed
Condition(s):Esophageal CancerLast Updated:November 7, 2022Terminated
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.